NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Sunday, May 19, 2024 0:04

Release 3.351
Cephaguard DC 150 mg intramammary ointment (NI)
 
Species: Cattle
Therapeutic indication: Pharmaceuticals: Antimicrobials: Intramammaries: Dry cow
Active ingredient: Cefquinome
Product:Cephaguard DC 150 mg intramammary ointment (NI)
Product index: Cephaguard DC
Cattle - milk: See notes
Cattle - meat: 2 days
Withdrawal notes: 1 day after calving when the dry period is more than 5 weeks. 36 days after treatment where the dry period is 5 weeks or less.
Incorporating:
Presentation
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 3 g pre-filled syringe contains:
Active substance:
Cefquinome (as sulphate): 150.0 mg
Excipients:
Qualitative composition of excipients and other constituents
Silica colloidal hydrophobic
Liquid paraffin
Homogeneous off-white oily ointment for intramammary infusion in dry cows.
Uses
Target species
Cattle (dry cows).
Indications for use for each target species
For the treatment of subclinical mastitis at drying off and the prevention of new bacterial infections of the udder during the dry period in the dairy cow caused by the following cefquinome-sensitive organisms: Streptococcus uberis, Streptococcus dysgalactiae, Streptococcus agalactiae, Staphylococcus aureus, coagulase negative staphylococci.
Dosage and administration
Intramammary use.
Single intramammary administration of 150 mg cefquinome.
The content of one syringe should be instilled gently into the teat of each quarter, immediately after the last milking.
Before instillation, the udder should be milked out completely. The teat and its orifice should be thoroughly cleaned and disinfected with the cleaning towel provided. Care should be taken to avoid contamination of the injector nozzle. Gently insert either about 5mm or the total length of the nozzle and instil the content of one syringe into each quarter. Disperse the product by gentle massage of the teat and udder.
The syringe must only be used once.
Contra-indications, warnings, etc
Contraindications
Not to be administered to animals which are known to be hypersensitive to cephalosporin antibiotics or other ß-lactam antibiotics.
Not to be administered to cows with clinical mastitis.
Withdrawal periods
Meat and offal: 2 days
Milk: 1 day after calving when the dry period is more than 5 weeks. 36 days after treatment where the dry period is 5 weeks or less.
Special precautions for use
Special precautions for safe use in the target species:
Use of the veterinary medicinal product should be based on susceptibility testing of the bacteria isolated from the animal. If it is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria.
Do not use the cleaning towel on teats with lesions.
In case of erroneous use during lactation the milk should be discarded for 35 days.
The efficacy of the veterinary medicinal product is only established against the pathogens mentioned in section "Uses”. Consequently, serious acute mastitis (potentially fatal) due to other pathogen species, mainly Pseudomonas aeruginosa, can occur after the drying off. Good hygienic practices should be thoroughly respected in order to reduce that risk; cows should be housed in a hygienic paddock far from the milking parlour and regularly checked several days after drying off.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious.
Do not handle this veterinary medicinal product if you know you are sensitised to penicillins or cephalosporins, or if you have been advised not to work with such preparations.
Handle this veterinary medicinal product with great care to avoid exposure. Personal protective equipment consisting of impervious gloves should be worn when handling the veterinary medicinal product. Wash exposed skin after use.
If you develop symptoms following exposure, such as skin rash, you should seek medical advice and show the package leaflet or the label to the physician. Swelling of the face, lips and eyes or difficulty in breathing are more serious symptoms and require urgent medical attention. Persons developing a reaction after contact with the veterinary medicinal product should avoid handling the product (and other cephalosporin and penicillin containing products) in future.
Wash hands after using the towels and wear protective gloves if skin irritation due to isopropyl alcohol is known or suspected. Avoid contact with eyes because isopropyl alcohol can cause eye irritation.
Adverse Reactions
Cattle (dry cows):
Very rare (<1 animal / 10,000 animals treated, including isolated reports):
Hypersensitivity reaction
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy, lactation or lay
Pregnancy:
There is no evidence of reproductive toxicity (incl. teratogenicity) in cattle. Laboratory studies in rats and rabbits have not produced any evidence of teratogenic, foetotoxic or maternotoxic effects.
The veterinary medicinal product is intended for use during pregnancy. In the clinical trials, no adverse effects on the foetus were observed.
Lactation:
Do not use during lactation.
Interactions
See Further Information with regard to cross-resistance in the cephalosporin group.
The neutralising effect of bacteriostatic acting pharmaceuticals (macrolides, sulfonamides and tetracyclines) on bactericidal effect of cefquinome has not been evaluated yet. Therefore there is no information about the safety and efficacy of this kind of association.
Pharmaceutical precautions
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years
Special precautions for storage
Do not store above 25C.
Disposal advice
Medicines should not be disposed of via wastewater or household waste.
Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable to the veterinary medicinal product concerned.
Legal category
Legal category: POM-V
Packaging quantities
- Box of 1 sachet of 4 applicators and 4 cleaning towels.
- Box of 5 sachets of 4 applicators and 20 cleaning towels.
- Box of 6 sachets of 4 applicators and 24 cleaning towels.
- Box of 15 sachets of 4 applicators and 60 cleaning towels.
- Box of 30 sachets of 4 applicators and 120 cleaning towels.
Not all pack sizes may be marketed.
Pre-filled syringe consisting of:
barrel made from high density polyethylene (HDPE)
plunger made from low density polyethylene (LDPE)
cap made from low density polyethylene (LDPE)
Further information
PHARMACOLOGICAL INFORMATION
ATCvet code: QJ51DE90.
Pharmacodynamics
The antibacterial drug cefquinome is a broad spectrum cephalosporin of the fourth generation which acts by inhibition of cell wall synthesis. It is bactericidal and is characterised by its broad therapeutic spectrum of activity and a high stability against penicillinases and beta-lactamases.
In vitro activity has been demonstrated against common Gram positive and Gram negative bacteria including Escherichia coli, Citrobacter spp., Klebsiella spp., Pasteurella spp., Proteus spp., Salmonella spp., Serratia marcescens, Arcanobacterium pyogenes, Corynebacterium spp., Staphylococcus aureus, coagulase negative Staphylococci, Streptococcus dysgalactiae, Streptococcus agalactiae, Streptococcus uberis, Streptococcus bovis.
Following bacterial species: Staphylococcus aureus, coagulase negative Staphylococci, Streptococcus uberis, Streptococcus dysgalactiae and Streptococcus agalactiae isolated from a field study conducted between 2000 and 2002 in Germany, France, Belgium and the Netherlands proved to be susceptible to cefquinome with MIC values between ≤ 0.008 µg/ml and 2.0 µg/ml.
An overview of the MIC90 of each bacterial pathogen is presented in the table below:
Bacterial species isolated
MIC90 (µg/ml)
Staphylococcus aureus
0.5
coagulase negative Staphylococci
0.5
Streptococcus uberis
0.063
Streptococcus dysgalactiae
≤0.008
Streptococcus agalactiae
0.032
Cefquinome as a fourth generation cephalosporin combines high cellular penetration and β-lactamase stability. In contrast to cephalosporins of previous generations, cefquinome is not hydrolysed by chromosomally–encoded cephalosporinases of the Amp-C type or by plasmid mediated cephalosporinases of some enterobacterial species. However, some extended spectrum beta-lactamases (ESBL) can hydrolyse cefquinome and cephalosporins of other generations. The potential for resistance development against cefquinome is rather low. High-level resistance to cefquinome would require the coincidence of two genetic modifications, i.e. hyperproduction of specific β-lactamases as well as decreased membrane permeability.
No cross-resistance has been described for the mechanism of alteration of penicillin binding protein encountered in Gram positive bacteria. Resistance due to changes in membrane permeability might result in cross-resistance.
Pharmacokinetics
Resorption of cefquinome from the udder to the systemic circulation is insignificant. The cefquinome concentrations reach a peak in the dry udder secretions after 7 to 14 days and slowly decrease during the dry period.
PHARMACEUTICAL PARTICULARS
Major incompatibilities None known.
Marketing Authorisation Number
VM 05653/3017
Significant changes
GTIN
GTIN description:Cephaguard DC 15x4ml Inj
GTIN:3597133053135
GTIN description:Cephaguard DC 4x4ml Inj
GTIN:3597133053142